Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

FEB 07, 2016 - Yahoo! News

A Must Read - Share

Celgene, Gilead Sciences shares could rise 30 percent: Barron's

The tumble in share prices for biotechnology stocks has created some buying opportunities, with drugmakers Celgene Corp and Gilead Sciences poised for a 30 percent rise over the next year, Barron's said. Celgene, which specializes in treatments for a blood plasma cell cancer called myeloma, could see double-digit growth for its Revlimid drug for years to come, with significant growth ...

Tags: Celgene, Gilead Sciences shares could rise 30 percent: Barron's,  Gilead Sciences Latest News

FEB 07, 2016 - Benzinga

A Must Read - Share

Barron's Picks And Pans: Kinder Morgan, Gilead Sciences And More

Featured stories in this weekend's Barron's offer a look at the prospects for MLPS, leading biotechs, small banks and more. The cover story makes a case for the price of oil to bottom at $20 a barrel. Also, check out a special report on the best mutual fund families.

Tags: Barron's Picks And Pans: Kinder Morgan, Gilead Sciences And More,  Gilead Sciences Latest News

FEB 03, 2016 - Benzinga

A Must Read - Share

Gilead Sciences Rallies Off Q4 Report

Gilead Sciences, Inc. (NASDAQ: GILD) shares are trading higher by $2.50 at $86.20 in Wednesday's session. The catalyst for the rally is a better-than expected Q4 for EPS by $0.33 with $400 million more in revenues. It also increased its dividend and added to its buyback plan.

Tags: Gilead Sciences Rallies Off Q4 Report,  Gilead Sciences Latest News

FEB 03, 2016 - Zacks Investment Research

A Must Read - Share

FEB 03, 2016 - Zacks Investment Research

A Must Read - Share